Clinical Trial Update: "The Effect of Trimetazidine on the Clinical Outcome of Acute Ischemic Stroke Patients" [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated the effect of trimetazidine on clinical outcomes in patients with acute ischemic stroke; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Trimetazidine (trimetazidine)

Snippet

Sponsor: Ain Shams University | Conditions: Acute Ischemic Stroke | Phase 3 | Status: COMPLETED